Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program

Kieren Mather, C. A. Christophi, K. A. Jablonski, W. C. Knowler, R. B. Goldberg, S. E. Kahn, T. Spector, Z. Dastani, D. Waterworth, J. B. Richards, T. Funahashi, F. X. Pi-Sunyer, T. I. Pollin, J. C. Florez, P. W. Franks

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Aims Baseline adiponectin concentrations predict incident Type2 diabetes mellitus in the Diabetes Prevention Program. We tested the hypothesis that common variants in the genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1, ADIPOR2) would associate with circulating adiponectin concentrations and/or with diabetes incidence in the Diabetes Prevention Program population. Methods Seventy-seven tagging single-nucleotide polymorphisms (SNPs) in ADIPOQ (24), ADIPOR1 (22) and ADIPOR2 (31) were genotyped. Associations of SNPs with baseline adiponectin concentrations were evaluated using linear modelling. Associations of SNPs with diabetes incidence were evaluated using Cox proportional hazards modelling. Results Thirteen of 24 ADIPOQ SNPs were significantly associated with baseline adiponectin concentrations. Multivariable analysis including these 13 SNPs revealed strong independent contributions of rs17366568, rs1648707, rs17373414 and rs1403696 with adiponectin concentrations. However, no ADIPOQ SNPs were directly associated with diabetes incidence. Two ADIPOR1 SNPs (rs1342387 and rs12733285) were associated with ∼18% increased diabetes incidence for carriers of the minor allele without differences across treatment groups, and without any relationship with adiponectin concentrations. Conclusions ADIPOQ SNPs are significantly associated with adiponectin concentrations in the Diabetes Prevention Program cohort. This observation extends prior observations from unselected populations of European descent into a broader multi-ethnic population, and confirms the relevance of these variants in an obese/dysglycaemic population. Despite the robust relationship between adiponectin concentrations and diabetes risk in this cohort, variants in ADIPOQ that relate to adiponectin concentrations do not relate to diabetes risk in this population. ADIPOR1 variants exerted significant effects on diabetes risk distinct from any effect of adiponectin concentrations.

Original languageEnglish
Pages (from-to)1579-1588
Number of pages10
JournalDiabetic Medicine
Volume29
Issue number12
DOIs
StatePublished - Dec 2012

Fingerprint

Adiponectin
Single Nucleotide Polymorphism
Incidence
Genes
Population
Population Control
Diabetes Mellitus
Alleles

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program. / Mather, Kieren; Christophi, C. A.; Jablonski, K. A.; Knowler, W. C.; Goldberg, R. B.; Kahn, S. E.; Spector, T.; Dastani, Z.; Waterworth, D.; Richards, J. B.; Funahashi, T.; Pi-Sunyer, F. X.; Pollin, T. I.; Florez, J. C.; Franks, P. W.

In: Diabetic Medicine, Vol. 29, No. 12, 12.2012, p. 1579-1588.

Research output: Contribution to journalArticle

Mather, K, Christophi, CA, Jablonski, KA, Knowler, WC, Goldberg, RB, Kahn, SE, Spector, T, Dastani, Z, Waterworth, D, Richards, JB, Funahashi, T, Pi-Sunyer, FX, Pollin, TI, Florez, JC & Franks, PW 2012, 'Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program', Diabetic Medicine, vol. 29, no. 12, pp. 1579-1588. https://doi.org/10.1111/j.1464-5491.2012.03662.x
Mather, Kieren ; Christophi, C. A. ; Jablonski, K. A. ; Knowler, W. C. ; Goldberg, R. B. ; Kahn, S. E. ; Spector, T. ; Dastani, Z. ; Waterworth, D. ; Richards, J. B. ; Funahashi, T. ; Pi-Sunyer, F. X. ; Pollin, T. I. ; Florez, J. C. ; Franks, P. W. / Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program. In: Diabetic Medicine. 2012 ; Vol. 29, No. 12. pp. 1579-1588.
@article{7a1359faa884456b9a0187dba44d6f44,
title = "Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program",
abstract = "Aims Baseline adiponectin concentrations predict incident Type2 diabetes mellitus in the Diabetes Prevention Program. We tested the hypothesis that common variants in the genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1, ADIPOR2) would associate with circulating adiponectin concentrations and/or with diabetes incidence in the Diabetes Prevention Program population. Methods Seventy-seven tagging single-nucleotide polymorphisms (SNPs) in ADIPOQ (24), ADIPOR1 (22) and ADIPOR2 (31) were genotyped. Associations of SNPs with baseline adiponectin concentrations were evaluated using linear modelling. Associations of SNPs with diabetes incidence were evaluated using Cox proportional hazards modelling. Results Thirteen of 24 ADIPOQ SNPs were significantly associated with baseline adiponectin concentrations. Multivariable analysis including these 13 SNPs revealed strong independent contributions of rs17366568, rs1648707, rs17373414 and rs1403696 with adiponectin concentrations. However, no ADIPOQ SNPs were directly associated with diabetes incidence. Two ADIPOR1 SNPs (rs1342387 and rs12733285) were associated with ∼18{\%} increased diabetes incidence for carriers of the minor allele without differences across treatment groups, and without any relationship with adiponectin concentrations. Conclusions ADIPOQ SNPs are significantly associated with adiponectin concentrations in the Diabetes Prevention Program cohort. This observation extends prior observations from unselected populations of European descent into a broader multi-ethnic population, and confirms the relevance of these variants in an obese/dysglycaemic population. Despite the robust relationship between adiponectin concentrations and diabetes risk in this cohort, variants in ADIPOQ that relate to adiponectin concentrations do not relate to diabetes risk in this population. ADIPOR1 variants exerted significant effects on diabetes risk distinct from any effect of adiponectin concentrations.",
author = "Kieren Mather and Christophi, {C. A.} and Jablonski, {K. A.} and Knowler, {W. C.} and Goldberg, {R. B.} and Kahn, {S. E.} and T. Spector and Z. Dastani and D. Waterworth and Richards, {J. B.} and T. Funahashi and Pi-Sunyer, {F. X.} and Pollin, {T. I.} and Florez, {J. C.} and Franks, {P. W.}",
year = "2012",
month = "12",
doi = "10.1111/j.1464-5491.2012.03662.x",
language = "English",
volume = "29",
pages = "1579--1588",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program

AU - Mather, Kieren

AU - Christophi, C. A.

AU - Jablonski, K. A.

AU - Knowler, W. C.

AU - Goldberg, R. B.

AU - Kahn, S. E.

AU - Spector, T.

AU - Dastani, Z.

AU - Waterworth, D.

AU - Richards, J. B.

AU - Funahashi, T.

AU - Pi-Sunyer, F. X.

AU - Pollin, T. I.

AU - Florez, J. C.

AU - Franks, P. W.

PY - 2012/12

Y1 - 2012/12

N2 - Aims Baseline adiponectin concentrations predict incident Type2 diabetes mellitus in the Diabetes Prevention Program. We tested the hypothesis that common variants in the genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1, ADIPOR2) would associate with circulating adiponectin concentrations and/or with diabetes incidence in the Diabetes Prevention Program population. Methods Seventy-seven tagging single-nucleotide polymorphisms (SNPs) in ADIPOQ (24), ADIPOR1 (22) and ADIPOR2 (31) were genotyped. Associations of SNPs with baseline adiponectin concentrations were evaluated using linear modelling. Associations of SNPs with diabetes incidence were evaluated using Cox proportional hazards modelling. Results Thirteen of 24 ADIPOQ SNPs were significantly associated with baseline adiponectin concentrations. Multivariable analysis including these 13 SNPs revealed strong independent contributions of rs17366568, rs1648707, rs17373414 and rs1403696 with adiponectin concentrations. However, no ADIPOQ SNPs were directly associated with diabetes incidence. Two ADIPOR1 SNPs (rs1342387 and rs12733285) were associated with ∼18% increased diabetes incidence for carriers of the minor allele without differences across treatment groups, and without any relationship with adiponectin concentrations. Conclusions ADIPOQ SNPs are significantly associated with adiponectin concentrations in the Diabetes Prevention Program cohort. This observation extends prior observations from unselected populations of European descent into a broader multi-ethnic population, and confirms the relevance of these variants in an obese/dysglycaemic population. Despite the robust relationship between adiponectin concentrations and diabetes risk in this cohort, variants in ADIPOQ that relate to adiponectin concentrations do not relate to diabetes risk in this population. ADIPOR1 variants exerted significant effects on diabetes risk distinct from any effect of adiponectin concentrations.

AB - Aims Baseline adiponectin concentrations predict incident Type2 diabetes mellitus in the Diabetes Prevention Program. We tested the hypothesis that common variants in the genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1, ADIPOR2) would associate with circulating adiponectin concentrations and/or with diabetes incidence in the Diabetes Prevention Program population. Methods Seventy-seven tagging single-nucleotide polymorphisms (SNPs) in ADIPOQ (24), ADIPOR1 (22) and ADIPOR2 (31) were genotyped. Associations of SNPs with baseline adiponectin concentrations were evaluated using linear modelling. Associations of SNPs with diabetes incidence were evaluated using Cox proportional hazards modelling. Results Thirteen of 24 ADIPOQ SNPs were significantly associated with baseline adiponectin concentrations. Multivariable analysis including these 13 SNPs revealed strong independent contributions of rs17366568, rs1648707, rs17373414 and rs1403696 with adiponectin concentrations. However, no ADIPOQ SNPs were directly associated with diabetes incidence. Two ADIPOR1 SNPs (rs1342387 and rs12733285) were associated with ∼18% increased diabetes incidence for carriers of the minor allele without differences across treatment groups, and without any relationship with adiponectin concentrations. Conclusions ADIPOQ SNPs are significantly associated with adiponectin concentrations in the Diabetes Prevention Program cohort. This observation extends prior observations from unselected populations of European descent into a broader multi-ethnic population, and confirms the relevance of these variants in an obese/dysglycaemic population. Despite the robust relationship between adiponectin concentrations and diabetes risk in this cohort, variants in ADIPOQ that relate to adiponectin concentrations do not relate to diabetes risk in this population. ADIPOR1 variants exerted significant effects on diabetes risk distinct from any effect of adiponectin concentrations.

UR - http://www.scopus.com/inward/record.url?scp=84865519965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865519965&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2012.03662.x

DO - 10.1111/j.1464-5491.2012.03662.x

M3 - Article

C2 - 22443353

AN - SCOPUS:84865519965

VL - 29

SP - 1579

EP - 1588

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 12

ER -